Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-7.32%
-0.94%
-1.99%
-0.53%
+0.14%
Most Trending
-7.32%
-0.94%
-1.99%
-0.53%
+0.14%
$ADSK caught the attention of HSBC analysts who upgraded Autodesk from Hold to Buy with a price target suggesting 17.30% upside potential. Trading at $320.91, the design software giant has been trending upward with its current price sitting above all major moving averages. The upgrade reflects growing confidence in Autodesk's business model transformation and its dominance in the architecture, engineering, and construction software markets. With an RSI of 56.69 indicating room to run before overbought territory, the stock appears positioned for continued momentum as digital design tools become increasingly essential across industries.
$CTVA emerged as a standout opportunity after JPMorgan upgraded Corteva from Neutral to Overweight, calling it a buying opportunity following Wednesday's pullback. The agricultural stock is trading at $63.49 with volume more than doubling to 11.20 million shares, suggesting strong institutional interest in the upgrade. Analysts see 34.97% upside potential and believe the stock is significantly undervalued after recent weakness. The company's position in the crop protection and seed technology sectors makes it a play on global agricultural demand, and the current downtrend may be reversing as value-focused investors take notice of the compelling risk-reward setup.
$NKE received multiple positive analyst actions with KeyBanc upgrading Nike from Sector Weight to Overweight with a $90 price target. Trading at $74.57 on elevated volume of 26.20 million shares, the athletic footwear giant is showing signs that its turnaround strategy is gaining traction. Multiple analysts pointed to progress in the company's latest quarterly results, suggesting management's restructuring efforts are beginning to bear fruit. Truist Securities also reiterated its Buy rating, adding to the positive sentiment surrounding the Dow component. The stock's sideways trend may be poised to break higher as operational improvements become more evident.
$CRL saw Barclays upgrade Charles River Laboratories from Equal-Weight to Overweight with 7.20% upside projected. The contract research organization is trading at $175.36 with volume nearly doubling its average, indicating strong buying interest following the upgrade. The company's essential role in pharmaceutical development and testing positions it as a beneficiary of continued drug discovery investments. With an RSI of 65.26 showing momentum but not yet extended, the stock could see further gains as the biotech sector continues to recover from its recent weakness.
$SKYW received a notable double upgrade from Raymond James, moving from Outperform to Strong Buy with 33.30% upside potential. SkyWest is trading at $100.07 as the regional airline operator navigates a recovering aviation market. Despite showing a downtrend on its moving averages with an RSI of just 27.82, the aggressive upgrade suggests analysts see the stock as oversold and ripe for a reversal. The Strong Buy rating is one of the highest conviction calls analysts can make, signaling significant optimism about the company's near-term prospects in the regional aviation space.
$BMA and $BBAR both received upgrades from HSBC, moving from Hold to Buy ratings for these Argentine bank stocks. Banco Macro is trading at $41.89 with 39.38% upside potential, while Banco BBVA Argentina sits at $8.27. Both upgrades reflect growing confidence in Argentina's financial sector as the country's economic reforms take hold. Volume on both stocks exceeded their averages, with traders responding positively to the improved analyst sentiment on Latin American banking exposure.
Yesterday at 01:25
Yesterday at 01:13
Yesterday at 12:56
Yesterday at 12:33
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.